相似文献
1
Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of arsenical dermatitis with preparations of BAL.
J Clin Invest. 1946 Jul;25(4):528-33.
2
Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
J Clin Invest. 1946 Jul;25(4):534-40.
3
Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
J Clin Invest. 1946 Jul;25(4):451-66. doi: 10.1172/jci101728.
4
The effect of 2,3-dimercaptopropanol (BAL) on the whole blood and plasma concentration of arsenic after mapharsen in cats.
J Pharmacol Exp Ther. 1946 Aug;87(4 Suppl):72-5.
5
The treatment by 2,3-dimercaptopropanol (BAL) of the systemic toxic effects of skin contamination with lewisite and phenyldichlorarsine.
J Pharmacol Exp Ther. 1946 Aug;87(4 Suppl):81-4.
6
Poisoning from inhalation of the vapors of lewisite and phenyldichlorarsine; its pathology in the dog and treatment with 2,3-dimercaptopropanol (BAL).
J Pharmacol Exp Ther. 1946 Aug;87(4 Suppl):76-80.
7
Arsenical dermatitis treated with BAL.
Br Med J. 1947 Aug 9;2(4518):227. doi: 10.1136/bmj.2.4518.227.
8
Arsenical dermatitis successfully treated with BAL.
Br Med J. 1947 Jul 26;2(4516):132. doi: 10.1136/bmj.2.4516.132.
9
The treatment of arsenical dermatitis with dimercaptopropanol (BAL).
Q J Med. 1948 Jan;17(65):49-79.
10
Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).
J Clin Invest. 1946 Jul;25(4):497-527. doi: 10.1172/jci101733.
Zotero 插件